共 80 条
[1]
Ben-Menachem E.(2004)Pregabalin pharmacology and its relevance to clinical practice Epilepsia 45 13-8
[2]
Bockbrader H.N.(2010)Clinical pharmacokinetics of pregabalin in healthy volunteers J Clin Pharmacol 50 941-50
[3]
Radulovic L.L.(2005)Pregabalin drug interaction studies: lack of effect on the pharmacokinetics of carbamazepine, phenytoin, lamotrigine, and valproate in patients with partial epilepsy Epilepsia 46 1407-13
[4]
Posvar E.L.(2010)Long-term efficacy and safety of pregabalin in patients with postherpetic neuralgia: results of a 52-week, open-label, flexible-dose study Masui 59 961-70
[5]
Brodie M.J.(2011)Efficacy and safety of pregabalin for treating neuropathic pain associated with diabetic peripheral neuropathy: a 14 week, randomized, double-blind, placebo-controlled trial Diabet Med 28 109-16
[6]
Wilson E.A.(2002)Herpes zoster and postherpetic neuralgia: incidence and risk indicators using a general practice research database Fam Pract 19 471-5
[7]
Wesche D.L.(2010)Epidemiology and economic burden of herpes zoster and post-herpetic neuralgia in Italy: a retrospective, population-based study BMC Infect Dis 10 230-80
[8]
Ogawa S.(2009)Herpes zoster (shingles) and postherpetic neuralgia Mayo Clin Proc 84 274-4
[9]
Suzuki M.(2002)Epidemiology and impact on quality of life of postherpetic neuralgia and painful diabetic neuropathy Clin J Pain 18 350-65
[10]
Arakawa A.(2004)Bridging the gap between pain research and treatment — update review: postherpetic neuralgia: diagnosis and treatment Pain Clinic 25 158-61